TMCI:NASDAQ
Treace Medical Concepts, Inc
$4.39
arrow_upward
+1.39%(+0.060) 1D
$4.39
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$4.37
High
$4.41
Low
$4.22
Mkt. cap
285.50M
Avg. vol.
242.01K
Volume
154.67K
52-wk high
$7.08
52-wk low
$1.17
EPS
-$0.93
Beta
1.48
Shares outstanding
65.04M
No. of employees
450
Open
$4.37
High
$4.41
Low
$4.22
Mkt. cap
285.50M
Avg. vol.
242.01K
Volume
154.67K
52-wk high
$7.08
52-wk low
$1.17
EPS
-$0.93
Beta
1.48
Shares outstanding
65.04M
No. of employees
450
News stories
From web sources and news partners
Investing.com Nigeria
·
22 hours ago
Form 4 Treace Medical Concepts Inc For: 2 October By Investing.com
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc